Coming Soon

Your medication.
Always protected.
Always monitored.

We're building something for the millions of people who rely on temperature-sensitive medication every day. Be the first to know when we launch.

✓ You're on the list. We'll be in touch.

No spam. Unsubscribe any time.

NHS Clinical Entrepreneur Cohort 2
WM Health Tech Innovation Accelerator
NHS DTAC-Aligned
Innovate UK RTO Grant Confirmed

Millions of people face the same daily challenge — and it goes largely unsolved.

Temperature-sensitive medication requires careful handling every single day. One lapse in conditions can compromise a dose — without the person ever knowing.

  • Current solutions address only part of the problem
  • Patients lack confidence that their medication is safe
  • The market for injectable medications is growing faster than ever
  • No pocket-sized, integrated solution currently exists
589M
Global diabetics today — growing to 854M by 2050
£6B+
Global temperature-controlled medication market
GLP-1
Fastest-growing injectable drug class globally
2027
Target UK market launch

An early opportunity in digital health.

We're building in a large, underserved market — backed by NHS programme support, confirmed grant funding, and strong academic and clinical partnerships. If you're interested in finding out more, we'd love to hear from you.

  • SEIS-eligible — significant UK tax advantages for early investors
  • Confirmed Innovate UK RTO grant; NIHR application submitted
  • Academic partners include Universities of Oxford, Warwick, and Birmingham
  • NHS Clinical Entrepreneur Programme Cohort 2
  • Platform potential across multiple injectable medication categories

Investment Overview

Structure Equity + SEIS
Total MVP Budget £370,000
Non-dilutive Funding ~£30,500 confirmed
Target UK Launch 2027
Stage Pre-seed
Request Investor Pack

Programme Support & Partners

University of Oxford University of Warwick University of Birmingham NHS Clinical Entrepreneur Programme Innovate UK CPI HealthTech SME

Be first to know
when we launch.

Join our growing community of patients, healthcare professionals, and investors following Novocaddy's journey.

I'm an Investor